Lukas Biomedical Inc. (6814.TWO)
TWD 30.05
(0.0%)
TWD 30.05
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 441.19 Million TWD | -8.02% |
| 2022 | 479.66 Million TWD | -9.71% |
| 2021 | 531.24 Million TWD | 1.46% |
| 2020 | 523.6 Million TWD | -5.85% |
| 2019 | 556.12 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 579.52 Million TWD | 31.35% |
| 2024 Q2 | 579.52 Million TWD | 0.0% |
| 2023 Q4 | 441.19 Million TWD | 0.0% |
| 2023 Q3 | 441.19 Million TWD | -5.41% |
| 2023 Q2 | 466.41 Million TWD | 0.0% |
| 2023 Q1 | 466.41 Million TWD | -2.76% |
| 2022 FY | 479.66 Million TWD | -9.71% |
| 2022 Q4 | 479.66 Million TWD | 0.0% |
| 2021 FY | 531.24 Million TWD | 1.46% |
| 2020 FY | 523.6 Million TWD | -5.85% |
| 2019 FY | 556.12 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -66.703% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 61.089% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -198.235% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 53.153% |
| NaviFUS Corp. | 490.53 Million TWD | 10.059% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 50.04% |
| TaiRx, Inc. | 833.74 Million TWD | 47.083% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 67.64% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 87.734% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -499.787% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 73.363% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -244.554% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 84.791% |
| AP Biosciences Inc | 890.75 Million TWD | 50.47% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 79.565% |
| RBC Bioscience Corporation | 753.79 Million TWD | 41.47% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 85.797% |
| EirGenix Inc. | 11.16 Billion TWD | 96.048% |
| Enimmune corporation | 604.82 Million TWD | 27.055% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 75.195% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -36.108% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 88.67% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 88.299% |
| TCI GENE Inc. | 1.16 Billion TWD | 62.16% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -16.606% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.128% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -7.54% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -46.56% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 19.6% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -11.173% |
| Neith Corporation | 192.15 Million TWD | -129.604% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 74.235% |
| VBI | 452.1 Million TWD | 2.413% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 78.747% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 62.488% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 61.957% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 85.704% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 16.622% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -49.769% |
| Visgeneer Inc. | 397.17 Million TWD | -11.082% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 62.012% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 23.022% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 64.005% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 33.628% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 58.001% |
| GlycoNex Incorporation | 1.55 Billion TWD | 71.588% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 94.826% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 66.918% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 88.842% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 83.726% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 41.062% |
| BiOptic Inc. | 613.77 Million TWD | 28.118% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 64.126% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 67.639% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 36.833% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 92.127% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 88.459% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 31.582% |
| Level Biotechnology Inc. | 822.67 Million TWD | 46.371% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 92.759% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 58.457% |
| Acepodia, Inc. | 6.81 Billion TWD | 93.53% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 88.47% |